Financial Wire

TSX Down 20 Points at Midday With Most Sectors Higher

-- The Toronto Stock Exchange is down 20 points at midday, with most sectors in the green.

Telecoms and info tech the best performers, up 1.5% and 1.3%, respectively.

In Canada, the focus was on the release of existing home sales data for March.

"Clearly, the market continues to struggle amid several headwinds, including soft job markets, economic uncertainty, falling population growth, and strained affordability," TD Economics said after a "soft" performance in Canadian home sales for March, following four straight monthly declines. TD added: "With these challenges in place, 2026 is shaping up to be another modest year for Canadian housing. Loose supply/demand balances should keep downwardly pressuring prices in B.C. and Ontario. Elsewhere, price growth should be firmer, but likely cool as the year progresses."

New listings were also flat during the month. With new listings and sales both barely moving, the sales-to-new listings ratio stayed at 47.8% in March. "This is well below the long-term average and signals modest price growth moving forward", TD said.

Average home prices were also flat in March, while the MLS home price index, a more 'like for like' measure, declined 0.4% m/m, and was down 4.7% on a year-on-year basis. Prices for detached units were down 0.3% m/m, while condo prices fell 0.9% m/m.

The Canadian Real Estate Association (CREA) on Thursday cut its home sales growth forecasts for this year amid a "tepid" start to the year for the economy and higher odds of a Bank of Canada rate hike later this year to tame inflation resulting from the oil price spike. Some 474,972 residential properties are forecast to be sold in 2026, a 1% increase over 2025, CREA wrote. This is below the 5.1% increase forecast that it released in January. The national average home price is forecast to rise 1.5% on an annual basis to $688,955 this year, less than the 2.8% growth CREA saw in January. In 2027, national home sales are forecast to climb a further 2.1% to 485,071 units. This could be revised above the 500,000 mark should higher interest rates prove unnecessary to fight inflation, added CREA.

In company news, First Capital REIT (FCR-UN.TO) is to be acquired by Choice Properties REIT (CHP-UN.TO) and and KingSett in a cash and units deal valued at $9.4 billion. The transaction also involves George Weston (WN.TO).

相关文章

Australia

板块动态:金融股午后走软

周四下午晚些时候,金融股下跌,纽约证券交易所金融指数和道富金融精选行业SPDR ETF(XLF)均下跌0.2%。 费城住房指数下跌0.5%,道富房地产精选行业SPDR ETF(XLRE)上涨0.8%。 比特币(BTC-USD)上涨0.4%至75,140美元,10年期美国国债收益率上涨2.7个基点至4.309%。 经济新闻方面,上周美国首次申请失业救济人数从前一周向下修正后的21.8万人降至20.7万人,低于彭博社对分析师调查后预期的21.3万人。 美国3月份工业生产下降0.5%,低于彭博社调查预期的0.1%增幅,而2月份的增幅经向上修正后为0.7%。 费城联邦储备银行4月份制造业指数升至26.7,高于3月份的18.1,而彭博社调查预期该指数将降至10。 纽约联邦储备银行4月份服务业指数从3月份的-22.6升至-14,高于彭博社调查预期的-20。 监管方面,美国证券交易委员会(SEC)正在就一项全面审查“综合审计追踪”(Consolidated Audit Trail)及其他用于监管美国证券市场的类似审计追踪系统征求公众意见。 公司方面,尽管营收低于华尔街预期,但嘉信理财(Charles Schwab,股票代码:SCHW)第一季度业绩在客户资产激增的推动下有所增长。高盛(GS)股价下跌7.7%。 路透社报道,受伊朗相关市场波动的影响,高盛(GS)利率交易业务在第一季度面临压力,部分持仓出现亏损。报道称,受利率交易、抵押贷款和信贷产品业绩疲软的影响,高盛固定收益、外汇和大宗商品收入下降10%至40亿美元。高盛股价基本持平。 Marsh & McLennan (MRSH)股价上涨4.6%,此前该公司公布的第一季度调整后净利润和收入均超出分析师预期。 彭博社报道,美国国家篮球协会(NBA)正与包括阿波罗全球管理公司(APO)、Ares Management (ARES)和Sixth Street在内的多家私人信贷公司就潜在的欧洲篮球联赛扩军融资事宜进行初步磋商。阿波罗股价上涨0.1%,Ares股价下跌2.7%。

$APO$ARES$GS$MRSH$SCHW
Japan

特朗普宣布以黎停火协议后,美国股市指数上涨。

周四收盘前,美国股市指数上涨,此前以色列和黎巴嫩同意停火10天,扫清了中东外交达成伊朗持久停火协议的一大障碍。 纳斯达克综合指数上涨0.2%,收于24069.1点;标普500指数上涨0.2%,收于7035.2点;道琼斯工业平均指数上涨0.2%,收于48583.5点。能源、房地产和科技板块领涨,医疗保健板块表现最差。 据《华尔街日报》报道,特朗普总统表示,美国可能在本周末与伊朗举行会谈。据《华尔街日报》报道,特朗普在白宫外告诉记者:“我们非常接近达成协议。” 报道称,特朗普表示,他不确定目前为期两周的停火是否需要延长。 周四早些时候,特朗普在Truth Social社交媒体平台上表示,黎巴嫩和以色列已同意从美国东部时间下午5点开始实施为期10天的停火。黎巴嫩总理纳瓦夫·萨拉姆表示欢迎这一决定。周四,特朗普在社交媒体上再次发文称,他将邀请黎巴嫩总统约瑟夫·奥恩和以色列总理本雅明·内塔尼亚胡前往白宫举行会谈。 与此同时,据路透社报道,美国国防部长皮特·赫格塞斯周四表示,对伊朗的海上封锁是当前停火期间“礼貌”行为的体现,如果接到命令,美军已准备好打击伊朗的发电厂和能源产业。 西德克萨斯中质原油期货价格上涨2.5%,至每桶93.77美元;布伦特原油期货价格上涨3.7%,至每桶98.58美元。

$^DJI$^IXIC$^SPX
Sectors

行业动态:医疗保健股午后下跌

周四下午晚些时候,医疗保健类股走软,纽约证券交易所医疗保健指数和道富医疗保健精选行业SPDR ETF (XLV) 均下跌0.7%。 iShares生物技术ETF (IBB) 下跌1.3%。 公司新闻方面,雅培公司 (ABT) 周四下调了全年盈利预期,以反映其收购癌症诊断公司Exact Sciences的影响。与此同时,这家医疗保健公司公布的第一季度业绩高于市场预期。其股价下跌超过5%。 吉利德科学公司 (GILD) 的第一季度业绩可能超出市场普遍预期,但加拿大皇家银行资本市场在一份报告中指出,Yeztugo的持续用药率低于预期,这可能对这款HIV暴露前预防药物的长期销售峰值构成潜在风险。吉利德股价下跌0.8%。 QuidelOrtho (QDEL) 股价暴跌28%。该公司周三晚间表示,预计第一季度未经审计的初步营收为6.15亿美元至6.2亿美元。FactSet调查的分析师此前预计营收为6.778亿美元。 美国一位高级卫生官员暗示计划放宽对某些肽类药物的限制后,Hims & Hers Health (HIMS) 的股价飙升超过12%。

$ABT$GILD$HIMS$QDEL